Sellas Life Sciences Group Inc (SLS)
Equity Ratio
94.69%
Quarterly · Period ending:
SLS Equity Ratio
Latest reported94.69%period ending
Latest reported94.69%period ending
SLS Quarterly Equity Ratio (100.00% → 94.69%)
Latest values, visible window
High-resolution chart · PNG
SLS equity ratio history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Equity Ratio |
|---|---|
| 94.6857% | |
| 94.075% | |
| 90.4601% | |
| 88.5074% | |
| 80.9441% | |
| 79.4113% | |
| 48.7083% | |
| 59.9585% | |
| 19.2671% | |
| 39.6333% | |
| -128.2521% | |
| -47.3287% | |
| 26.0853% | |
| 45.2481% | |
| 23.1629% | |
| 48.4481% | |
| 59.1649% | |
| 18.7786% | |
| 76.9932% | |
| 70.107% | |
| 76.5977% | |
| 70.8367% | |
| 60.7201% | |
| 42.9413% | |
| 26.0645% | |
| 47.3511% | |
| 36.6849% | |
| 49.5113% | |
| 57.2741% | |
| 19.7628% | |
| 31.008% | |
| 47.9776% | |
| -7.7659% | |
| -3.9361% | |
| 6.1743% | |
| 29.511% | |
| 31.5867% | |
| 38.6652% | |
| 43.5444% | |
| 32.8501% | |
| 27.5434% | |
| 18.7041% | |
| 16.4504% | |
| 39.213% | |
| 48.4127% | |
| 54.4016% | |
| 46.0429% | |
| 38.8203% | |
| 35.2671% | |
| 50.389% | |
| 6.6905% | |
| 37.9381% | |
| 24.5653% | |
| 37.9359% | |
| 50.4783% | |
| 40.2506% | |
| 49.067% | |
| -37.4716% | |
| 32.6531% | |
| 15.5264% | |
| 30.4763% | |
| 27.197% | |
| 32.504% | |
| 34.2322% | |
| 54.3398% | |
| 43.846% | |
| 11.8522% | |
| 59.0371% | |
| 63.1713% | |
| 81.2633% | |
| 86.5721% | |
| 91.1129% | |
| 90.3106% | |
| 83.2325% | |
| 89.1002% | |
| 88.1% | |
| 100% |